Clinical trial Recruiting at 1 site Interventional Ages 18 to 40

Ways to Boost Quadriceps Power After ACL Surgery

Official title: Clinical Interventions to Acutely Enhance Quadriceps Output After Anterior Cruciate Ligament Reconstruction

Run by University of Wisconsin, Madison · NCT07674784 · Data updated 2026-11-12

This study tests whether neuromuscular electrical stimulation or hamstring vibration can help people 2–4 months after ACL reconstruction increase their quadriceps strength.

Quick facts

Study typeInterventional
Ages18 Years to 40 Years
SexAll
Enrollment22 (estimated)
SponsorUniversity of Wisconsin, Madison
Academic / other
Locations1 site (Madison, Wisconsin)
StatusRecruiting
StartedJuly 17, 2026
Main results expectedAugust 2027
Study endsAugust 2027
Registry record updatedNovember 3, 2026
Trial IDNCT07674784 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults 2–4 months post-ACLR with the ability to walk without an assistive device and no contraindications to NMES.

Probably not a fit

Individuals with bilateral ACLR history on the same leg, significant prior lower-extremity surgery, or severe pain during strengthening may see limited or no benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants who recently had ACL reconstruction are randomized to receive either 20 minutes of NMES during rehab exercises or 20 minutes of hamstring vibration, in two 60-minute sessions at least a week apart. Each visit includes a brief warm-up, patient surveys, pre- and post-intervention leg tests, and the assigned intervention to measure acute effects on quadriceps performance. The trial aims to see if these approaches reduce neural inhibition and boost quadriceps strength, and whether responses differ based on initial inhibition levels. The study plans to enroll about 22 participants and follows them for 2–3 weeks. The primary focus is on short-term changes in quadriceps performance after these interventions in people within 4 months of ACL reconstruction.

Why it matters

Potential benefit: If successful, the interventions could provide quick, non-drug options to improve quadriceps strength after ACL surgery.

How similar studies have gone: Prior clinical use of NMES and vibration in similar post-ACL settings has shown potential benefits, but results vary by individual and context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Have undergone ACLR within the previous 4 months
* Are at least 2 months post-ACLR

Exclusion Criteria:

* A history of ACLR on both legs
* Since the most recent ACLR:

  * secondary lower extremity surgery
  * leg or foot fracture
* Unable to walk without an assistive device
* Pain of greater than 5/10 during quadriceps strengthening exercises with the surgical limb
* Cannot achieve 90 degrees of knee flexion with the surgical limb
* People with contraindications to NMES
* Anyone who had a previous skin reaction to NMES or attempted but could not tolerate NMES
* Peripheral neuropathy or other neurological conditions

Where it's running

  • UW Health
    Madison, Wisconsin, United States
    Recruiting

Study contacts

  • Principal investigator: Daniel Cobian, DPT, PhD — University of Wisconsin, Madison
  • Study coordinator: Daniel Cobian, DPT, PhD
  • Email: cobian@ortho.wisc.edu
  • Phone: 608-262-0013

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.